Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team.

Maria Olívia Barboza Zanetti João Paulo Vilela RodriguesFabiana Rossi VaralloRenato Luiz Guerrino CunhaBelinda Pinto SimõesLeonardo Régis Leira Pereira

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

The pharmacotherapy follow-up allowed detecting several DRPs and performing interventions of high clinical relevance and acceptability, in addition to improving adherence and individualizing the pharmacotherapy.

Keyphrases

induced apoptosis
stem cell transplantation
smoking cessation
cell cycle arrest
bone marrow
physical activity
palliative care
cell death
type diabetes
stem cells
quality improvement
adipose tissue
low dose
high dose
insulin resistance
weight loss